An HIV prevention pill that could provide a month of protection per tablet has been given the green light to proceed to pivotal trials to test its efficacy. Spotlight reports on new findings on the ...

Nairobi, Kenya | THE INDEPENDENT | Researchers at the  University of Nairobi, Centre for Epidemiological Modelling and ...

AIDS AND HIV, the virus that causes it, once sparked fear across the world. Apocalyptic forecasters in early 2002 reckoned ...

Sudanese climate activist Roaa should have been leading meetings with other youth advocates at a United Nations climate ...

The global community has committed to the Triple Elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Younger children living with HIV with low BMI for their age were more likely than older children to fail first-line ...

The Trump administration's halted funding to the President's Emergency Plan for AIDS Relief (PEPFAR) and dissolution of the U.S. Agency for International Development (USAID) have had devastating ...

Countries worldwide must step up to support the fight against HIV or face the “ticking time bomb” left by the wholesale ...